[22-hydroxy-1,2,6,6,10,19-hexamethyl-16-oxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-21-oxahexacyclo[12.11.0.02,11.05,10.015,23.018,23]pentacos-14-en-8-yl] acetate

Term ID

CHEBI:212727

Synonyms

[22-hydroxy-1,2,6,6,10,19-hexamethyl-16-oxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-21-oxahexacyclo[12.11.0.02,11.05,10.015,23.018,23]pentacos-14-en-8-yl] acetate

Definition

References

Chemspider:7985957

Ontology

ChEBI ( EBI )

Relationships

is a type of: diterpene glycoside

diterpene glycoside Show first 5 Terms

Phenotype

Phenotype resulting from [22-hydroxy-1,2,6,6,10,19-hexamethyl-16-oxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-21-oxahexacyclo[12.11.0.02,11.05,10.015,23.018,23]pentacos-14-en-8-yl] acetate

Phenotype where environments contain [22-hydroxy-1,2,6,6,10,19-hexamethyl-16-oxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-21-oxahexacyclo[12.11.0.02,11.05,10.015,23.018,23]pentacos-14-en-8-yl] acetate

Phenotype modified by environments containing [22-hydroxy-1,2,6,6,10,19-hexamethyl-16-oxo-7-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-21-oxahexacyclo[12.11.0.02,11.05,10.015,23.018,23]pentacos-14-en-8-yl] acetate

Human Disease Model